Chris Miller
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections (NCT03331445) | Chris Miller | 2017-10-24 |
Track Chris Miller automatically
Every clearance here is in the API, with alerts when new ones post.